{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Cannulation Strategies in Aortic Arch Surgery"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomised to either right axillary or innominate artery cannulation."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were patients undergoing proximal aortic arch surgery. Eligibility criteria included patients with ATAAD."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention group received right axillary artery cannulation, while the control group received innominate artery cannulation."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the efficacy of different cannulation strategies for cerebral protection."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was the incidence of new severe ischemic lesions, assessed by diffusion-weighted magnetic resonance imaging postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applicable due to the nature of the intervention."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 222 participants were randomised, with 111 in each group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "The analysis was conducted on an intention-to-treat basis."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The incidence of new severe ischemic lesions was similar between the axillary group (34%) and the innominate group (38.8%)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Thirty-day mortality and adverse events, including seizures and delirium, were comparable between groups."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Not specified."
      }
    },
    "total_score": 16,
    "max_score": 25
  },
  "model": "gpt-4o"
}